FDA APPROVED DRUGS
FDA approved drugs - November 2012
Brithvi V
Cometriq (cabozantinib) is a pan-tyrosine kinase inhibitor. It is specifically approved for the treatment of progressive, metastatic medullary thyroid cancer.
